Abstract
Subanesthetic rather than anesthetic doses are thought to bring the rapid antidepressant effects of the NMDAR (N-methyl-D-aspartate receptor) antagonist ketamine. Among molecular mechanisms, activation of BDNF receptor TrkB along with the inhibition of GSK3 beta (glycogen synthase kinase 3 beta) are considered as critical molecular level determinants for ketamine's antidepressant effects. Hydroxynorketamines (2R,6R)-HNK and (2S,6S) HNK), non-anesthetic metabolites of ketamine, have been proposed to govern the therapeutic effects of ketamine through a mechanism not involving NMDARs. However, we have shown that nitrous oxide, another NMDAR blocking anesthetic and a putative rapid-acting antidepressant, evokes TrkB-GSK3 beta signaling alterations during rebound slow EEG (electroencephalogram) oscillations. We investigated here the acute effects of ketamine, 6,6-d(2)-ketamine (a ketamine analogue resistant to metabolism) and cis-HNK that contains (2R,6R) and (2S,6S) enantiomers in 1:1 ratio, on TrkB-GSK3 beta signaling and concomitant electroencephalographic (EEG) alterations in the adult mouse cortex. Ketamine dose-dependently increased slow oscillations and phosphorylations of TrkB(Y816) and GSK3 beta(59) in crude brain homogenates (i.e. sedative/anesthetic doses ( > 50 mg/kg, i.p.) produced more prominent effects than a subanesthetic dose (10 mg/kg, i.p.)). Similar, albeit less obvious, effects were seen in crude synaptosomes. A sedative dose of 6,6-d(2)-ketamine (100 mg/kg, i.p.) recapitulated the effects of ketamine on TrkB and GSK3 beta phosphorylation while cis-HNK at a dose of 20 mg/kg produced negligible acute effects on TrkB-GSK3 beta signaling or slow oscillations. These findings suggest that the acute effects of ketamine on TrkB-GSK3 beta signaling are by no means restricted to subanesthetic (i.e. antidepressant) doses and that cis-HNK is not responsible for these effects.
| Original language | English |
|---|---|
| Article number | 107684 |
| Journal | Neuropharmacology |
| Volume | 157 |
| Number of pages | 9 |
| ISSN | 0028-3908 |
| DOIs | |
| Publication status | Published - Oct 2019 |
| MoE publication type | A1 Journal article-refereed |
Fields of Science
- 317 Pharmacy
- 3112 Neurosciences
- Ketamine
- Sedation
- Slow oscillations
- Antidepressant
- Anesthesia
- Synaptosomes
- TRKB NEUROTROPHIN RECEPTOR
- TREATMENT-RESISTANT DEPRESSION
- ELECTROCONVULSIVE-THERAPY
- ANTIDEPRESSANT ACTIONS
- AMPA RECEPTOR
- ISOFLURANE-ANESTHESIA
- PREFRONTAL CORTEX
- NITROUS-OXIDE
- S-KETAMINE
- DELTA-EEG
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver